Variations in UK screening for Down's syndrome:
This article was originally published in Clinica
There are wide variations in the methodology and markers used for antenatal screening in the UK for Down's syndrome, says a new UK study in the October 9 edition of The Lancet. The survey shows that antenatal screening with serum or ultrasound markers has increased over the past decade. However, the most common method offered by health authorities - the double test, AFP and total or free b-hCG - is not the best, says the study.
You may also be interested in...
Operation Warp Speed will hold back initial shipments to ensure two-dose regimens can be completed; 15 December is ‘chalk’ target date for emergency authorization of Pfizer vaccine, OWS’ Gustave Perna says, calling it only a projection that does not impinge on FDA authority. Sending only half shipments also eases burden on cold shortage capacity at state and local level, he says.
CMS acknowledges stakeholders may need more details about the plan before it is finalized and a delay will give the agency more time to ‘consider the issue.’
Private Company Edition: Venture capital financings didn’t take a break during Thanksgiving week. In addition to the $800m Resilience raised to fund manufacturing services, SomaLogic closed a $121m series A round to fund its proteomic tools for drug discovery and diagnostics development.